跳至主要内容
临床试验/IRCT20200427047215N1
IRCT20200427047215N1招募中2 期

Efficacy and safety of oral indomethacin for treatment of covid 19 induced pneumonia

Isfahan University of Medical Sciences Vice Chancellor for Research and Technology0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 75 years(—)
性别
All

入选标准

  • Patients 18 to 75 years old hospitalized
  • Patient with SpO2:85-89% on room air at admission (if correct with nasal O2 maximum 6 liter/min to SpO2>=90 )
  • Patients with SpO2: 90-93% and RR>=30
  • clinical compatible patients with positive RT-PCR test or consistent HRCT to covid19 pneumonia
  • Sign the study participation form

排除标准

  • Known hypersensitivity to indomethacin or any components of NSAIDs
  • History of asthma, urticarial, or other allergic type reaction after taking aspirin or NSAIDs
  • GFR less than 60ml/minute/1.7m2
  • Patients with active gastrointestinal bleeding
  • The need for intubation in the first 24 hours of hospitalization
  • Patients with multi organ failure
  • Patients with shock state at admission
  • Pregnant woman
  • Lactating woman
  • Patients with active peptic ulcer
  • Consumption of NSAID on admission

研究者

发起方
Isfahan University of Medical Sciences Vice Chancellor for Research and Technology

相似试验